Home | Welcome to Contract Pharma   
Last Updated Tuesday, September 2 2014
Print RSS Feed

Topics - Drug Development


Refine by Date:
From: To:
Published August 29, 2014
PODRAS platform technology aims to prevent overdose Read More »
Published August 28, 2014
Initiates Phase II trial of AVP-786 in major depressive disorder Read More »
Published August 26, 2014
Recipharm Venture Fund invests $1.15 million in Isofol Read More »
Published August 25, 2014
Phase 1/2 trial to evaluate ADXS-PSA and pembrolizumab in prostate cancer Read More »
Published August 25, 2014
Expands respiratory portfolio globally Read More »
Published August 20, 2014
Will initiate a Phase I trial of ES414 within the next six months Read More »
Published August 20, 2014
Will evaluate combination regimen of nivolumab and ABRAXANE Read More »
Published August 15, 2014
Advances ISIS-SMN Rx in Spinal Muscular Atrophy Read More »
Published August 14, 2014
LiRIS candidate in Phase II development for cystitis, bladder pain Read More »
Published August 12, 2014
Expands presence in dermatology market Read More »
Published August 12, 2014
MannKind to manufacture inhaled insulin product for global commercialization Read More »
Published August 8, 2014
Fixed-dose combination tablet seeks to address pain and opioid-related illness Read More »
Published August 5, 2014
Aims to identify microRNAs as biomarkers for MS Read More »
Published August 5, 2014
Expands development of RNA-targeting molecules Read More »
Published August 4, 2014
Triggers €750K payment to Vernalis Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On